This website is intended for healthcare professionals only
Specialities

Specialities

Arrhythmia
Atherosclerosis
Atrial Fibrillation
Cardiovascular Disease
Congenital Conditions
COVID-19
Electrophysiology
Heart Failure
Hypertension
Imaging
Interventional Cardiology
Obesity
Syncope
Stroke
Thrombosis
Rare Disease Day
Search

Trending Topic
16 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension knowledge gaps: A patient–caregiver comparison from a tertiary care centre in Northern India

Bhupinder Singh, Kamlesh Sharma, Navdeep Dhillon

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

Heart International. 2026;20(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

David Albert: Why is the Heart Rhythm Congress so important?

2 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 12th 2022

As the Heart Rhythm Congress 2022 has just finished, Dr David Albert (AliveCor, Mountain View, CA, USA) shares why the conference is so important in bringing together physicians, nurses, patients, patients advocates and all those interested in the care and diagnosis of arrhythmia patients.

Disclosures: David Albert is an employee and major stock shareholder of AliveCor.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the Heart Rhythm Congress 2022

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Flecainide to prevent atrial arrhythmia in the AFLOAT study

Gilles Montalescot

touchCARDIO coverage of data presented at ESC 2024 touchCARDIO spoke with Professor Gilles Montalescot, Professor of Cardiology, Sorbonne University, Paris, France and Chairman of the ACTION study group to get the results from the AFLOAT randomised study, presented at ESC 2024. AFLOAT aimed to evaluate whether flecainide could prevent atrial arrhythmia after patent foramen ovale (PFO) […]

Advertisement

    • Related Videos in Arrhythmia

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup